WHC is still in active development. Read this to understand our approach.
depiction of QOIGKGMMAGJZNZ-UHFFFAOYSA-N.svg
isomerdesign

Gepirone

Verificar en isomerdesign

drugmap

Gepirone

Verificar en drugmap

drugmap

Gepirone

Verificar en drugmap

wiki

Gepirone

Verificar en wiki

Data

InChI: InChI=1S/C19H29N5O2/c1-19(2)14-16(25)24(17(26)15-19)9-4-3-8-22-10-12-23(13-11-22)18-20-6-5-7-21-18/h5-7H,3-4,8-15H2,1-2H3

Sinónimos: 4,4-dimethyl-1-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-2,6-piperidinedione, Ariza, AC1Q6F8Q, Variza, Gepirona [Spanish], 4,4-dimethyl-1-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]piperidine-2,6-dione, 3,3-dimethyl-1-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]glutarimide, Gepirone ER, Gepironum [Latin], CHEMBL284092, 4,4-Dimethyl-1-(4-(4-(pyrimidin-2-yl)piperazin-1-yl)butyl)piperidine-2,6-dione, AC1L1IK6, UNII-JW5Y7B8Z18, JW5Y7B8Z18, MJ 13805-1, Gepirone [INN], gepiron ER, ORG-13011(Gepirone),Gepirone, MJ 13805, MJ-13805, Gepironum, BMY-13805, BMY 13805, Travivo, Gepirona,83928-76-1, 2,6-Piperidinedione, 4,4-dimethyl-1-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-, AK115965

Estimated data

Solubilidad: -2.066 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 54.4% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.